FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’
In Brief: ACS Begins Narrowing List of Job Applicants; IL-2 Gets BRM Ok; Pitot Resigns McArdle Post
Kessler Says FDA Working To Expedite Secondary Approvals
NIH Strategic Plan To be Unveiled In San Antonio
DCPC Advisors Okay Continuation of Children’s Diet Study
Eight Centers Picked To Host Regional Breast Cancer Summits
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home









